Last update July 21, 2017
Very Low Risk
Excreted into breast milk in quantities that would be clinically significant, however, intestinal absorption by infant's gut is hampered because of formation of chelating products by union with the milk's calcium.
No side-effect found among breastfed infants from treated mothers. Plasma levels in those infant were low or undetectable.
Long-term treatments (over 3-4 weeks) as for treatment of acne may cause damage to the growth cartilage, teeth discoloration and imbalance of intestinal flora. Thus, a safer alternative should be looked at. (See acne)
Be aware of false negative results that may be obtained from infants with bacterial cultures when the mother is on antibiotics.
The American Academy of Pediatrics has rated it (2001) as compatible with breastfeeding.
We do not have alternatives for テトラサイクリン since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM